How Would You React To A 2,000 Point Dow Jones Drop? -
Sheila Jamison and Rich Jamison A pullback of 2,000-3,000 points in the Dow Jones Industrial Average is not out of the realm of possibility. Got your attention, didn’t it? The real question is how significant would that be. Of course, that is up to...
Bond Fund’s Assets Shrink 88% in 1 Day -
Sheila Jamison and Rich Jamison Franklin Templeton Investments (FT) held almost all of WisdomTree’s Australia & New Zealand Debt ETF (AUNZ). The fund has returned over 12% this year when both Australia and New Zealand bonds rallied after their...
Nobody Ever Said It Had To Make Sense! -
Sheila Jamsion and Rich Jamison Are Stocks Due for a Correction? We revisit the drawdowns, pullbacks and corrections topic when markets get a bit jittery. The media pundits’ cry of “scary” motivates us. Keep in mind that the media’s primary...
Perspective for October Markets: Redux -
By Sheila Jamison & Rich Jamison Repeating our phrasing from this time in 2014, the month of October has long engendered a “love, hate” relationship with investors. Some of the more notorious market meltdowns have occurred, or at least escalated...
Today’s Biotechs: Fact and Fiction -
by Sheila Jamison & Rich Jamison Pharmaceuticals – and the volatile biotechs – have been in the headlines since Turing Pharmaceuticals (a startup run by a former hedge fund manager) bought an existing generic drug, Daraprim. Turing then raised...